magnifying glass
logo for Astellas Pharma

Astellas Pharma

Manufacturing · Japan · 15,455 Employees

Get Full Access

Who is Astellas Pharma

Astellas Pharma is engaged in the manufacturing, marketing, import, and export of pharmaceuticals. It is headquartered in Tokyo, Japan.Read More

Headquarters

Headquarters:

2-5-1, Nihonbashi-Honcho, Chuo-Ku, Tokyo, Tokyo, Japan
Phone Number

Phone Number:

+81 3-3244-3000
Revenue

Revenue:

$11 Billion
Stock Symbol

Stock Symbol:

4503
Astellas Pharma's Social Media
SIC Code 28,283
NAICS Code 62151,42421
Ticker TYO: 4503
Popular Searches:

Astellas Pharma Inc.

Astellas Pharma Inc

Astellas Pharma US , Inc.

Astellas

Astellas Pharma , Inc.

Top Competitors of Astellas Pharma

Employess
6,000
revenue
$1 Billion

1

Employess
5,222
revenue
$33 Billion

2

Employess
47,495
revenue
$18 Billion

3

Employess
6,000
revenue
$2 Billion

4

Employess
21,650
revenue
$2 Billion

5

Employess
30,250
revenue
$42 Billion

6

Astellas Pharma's Org Chart

Kenji Yasukawa
Kenji Yasukawa

President & Chief Executive Officer

PhonePhoneEmailEmail
Naoki Okamura
Naoki Okamura

Corporate Executive VP, Chief Strat...

PhonePhoneEmailEmail
Bernhardt Zeiher
Bernhardt Zeiher

Chief Medical Officer

PhonePhoneEmailEmail

PhonePhoneEmailEmail

Astellas Pharma Email Formats

Astellas Pharma uses at least 5 email formats with first.last (ex. John.Smith@astellas.com) being used 68.6% of the time

Get Verified Emails

Astellas Pharma Email FormatsPercentage
Illustration of an envelope

Astellas Pharma Company Metrics

Company Insights
Employee Growth Rate
Revenue
QuarterRevenue

'21 - Q1

11546806000

'21 - Q2

11796370000

Acquisitions & Subsidiaries

Dec 08, 2018

Iota Biosciences

Jun 12, 2018

Ogeda

Jul 11, 2014

VESIcare

Dec 07, 2013

Euroscreen

Cadus

Cell Pathways

See More Acquisitions & Subsidiaries

Astellas Pharma's Tech Stack

Microsoft Exchange Server 2010

By

Microsoft

SAP Warehouse Management

By

SAP

Apollo

By

Apollo

Microsoft SQL Server Reporting

By

Microsoft
See more technologies

Astellas Pharma News & Media

Astellas Submits Fezolinetant New Drug Application to U.S. FDA

Application targets treatment of moderate to severe vasomotor symptoms associated (VMS) with menopause TOKYO, June 23, 2022 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") today announced a New Drug Application (NDA) for fezolinetant...

Astellas Celebrates the Opening of Its New Large-Scale Gene Therapy Manufacturing Facility in North Carolina

- 135,000 square-foot state-of-the-art gene therapy manufacturing facility located in Sanford, N.C., officially opened June 8 - Facility to support clinical- and commercial-scale manufacturing of Astellas' adeno-associated virus (AAV) vectors for gene therapies - Astellas' $100 million...

Interstitial Cystitis Drugs Market - 36% of Growth to Originate from North America| Evolving Opportunities with Astellas Pharma Inc. & Bayer AG | 17000+ Technavio Reports

NEW YORK, June 1, 2022 /PRNewswire/ -- The "Interstitial Cystitis Drugs Market by Type (Oral therapy and Intravesical therapy) and Geography (North America, Europe, Asia, and ROW) - Forecast and Analysis 2021-2025" report has been added to Technavio's offering. With ISO 9001:2015...
Subscribe to "Astellas Pharma" News

Frequently Asked Questions regarding Astellas Pharma

Where are Astellas Pharma’s headquarters?

Astellas Pharma’s headquarters are in 2-5-1, Nihonbashi-Honcho, Chuo-Ku, Tokyo, Tokyo, Japan

What is Astellas Pharma’s phone number?

Astellas Pharma’s phone number is +81 3-3244-3000

What is Astellas Pharma’s stock symbol?

Astellas Pharma’s stock symbol is 4503

What is Astellas Pharma’s official website?

Astellas Pharma’s official website is www.astellas.com

What is Astellas Pharma’s Revenue?

Astellas Pharma’s revenue is $11 Billion

What is Astellas Pharma’s SIC code?

Astellas Pharma’s SIC: 28,283

What is Astellas Pharma’s NAICS code?

Astellas Pharma’s NAICS: 62151,42421

How many employees are working in Astellas Pharma?

Astellas Pharma has 15,455 employees

What is Astellas Pharma’s industry?

Astellas Pharma is in the industry of: Manufacturing, Pharmaceuticals, Drug Stores & Pharmacies

Who are Astellas Pharma’s main competitors?

Astellas Pharma's main competitors are: LEO Pharma, Shionogi & Co, Takeda, Amneal

What companies has Astellas Pharma acquired?

Astellas Pharma has acquired the companies: Iota Biosciences, Ogeda, VESIcare, Euroscreen

What is Astellas Pharma's tech stack?

The technologies that are used by Astellas Pharma are: Microsoft Exchange Server 2010, SAP Warehouse Management, Apollo, Microsoft SQL Server Reporting

Who is Astellas Pharma's CEO?

Astellas Pharma's CEO is Kenji Yasukawa

Who is Astellas Pharma's CFO?

Astellas Pharma's CFO is Naoki Okamura

See more information about Astellas Pharma
4.4/5 on G2 Crowd